Which feature best distinguishes sickle cell disease (HbSS) from sickle cell trait (HbAS) in an Indian patient presenting with recurrent pain crises?

Explanation

## Distinguishing Sickle Cell Disease from Sickle Cell Trait ### Clinical Presentation Difference **Key Point:** Vaso-occlusive pain crises in childhood are pathognomonic for sickle cell disease (HbSS), not trait. Patients with HbAS rarely experience crises except under extreme stress (high altitude, severe infection, or severe dehydration). ### Comparison Table | Feature | HbSS (Disease) | HbAS (Trait) | | --- | --- | --- | | **Genotype** | Homozygous (β^S^/β^S^) | Heterozygous (β^A^/β^S^) | | **HbS percentage** | 80–95% | 35–45% | | **Vaso-occlusive crises** | Frequent, from childhood | Rare; only extreme stress | | **Hemolysis** | Chronic, severe | Minimal or absent | | **Organ damage** | Progressive (spleen, kidney, bone) | None | | **Life expectancy** | Reduced (median ~50–60 years) | Normal | | **Sickling under hypoxia** | Occurs readily | Occurs only under severe hypoxia | ### Why Other Options Are Misleading **High-Yield:** HbS is present on electrophoresis in BOTH disease and trait — this is not discriminatory. Similarly, both will show positive solubility tests because both contain HbS. The key difference is the **clinical phenotype**: only HbSS causes recurrent childhood pain crises. **Clinical Pearl:** Patients with sickle cell trait are often asymptomatic and discovered incidentally on screening. They do NOT require prophylactic penicillin or transfusion support. The presence of recurrent pain crises in childhood is the red flag for homozygous disease.